The global peripheral vascular devices market size reached US$ 11.6 Billion in 2023. Looking forward, the market is projected to reach US$ 19.8 Billion by 2032, exhibiting a growth rate (CAGR) of 6.12% during 2023-2032.
Peripheral vascular disease (PVD) is a circulatory condition caused due to the narrowing, blockage, or spasms in the blood vessels located outside the heart and brain. Such occurrences reduce the blood flow through the vessels, resulting in weakness, pain, gangrene, hair loss on the legs, numbness, and muscle heaviness. Peripheral vascular devices, such as angioplasty catheters, peripheral guidewires, vena cava filters, stent grafts, and embolic protection devices (EPD), are used to treat artery blockages and narrowing. These blockages, particularly found in the peripheral vasculature, are caused by plaque build-up, which limits the blood vessels and reduces blood flow to the body parts. Peripheral vascular devices are safe, minimize the risk of infection and irritation, improve blood flow, and supply oxygenated blood through arteries.
Apart from this, the growing inclination toward minimally invasive surgeries (MIS) due to fewer complications, less postoperative pain, shortened hospital stay, and faster recovery times are providing an impetus to the market growth. Moreover, the widespread adoption of atherectomy devices owing to the increasing prevalence of atherosclerosis, obesity, and lifestyle-related disorders is positively influencing the market growth. Other factors, including the significant growth in the healthcare industry, rising expenditure capacities of consumers, and extensive research and development (R&D) activities, are anticipated to drive the market toward growth.
2. What is the expected growth rate of the global peripheral vascular devices market during 2024-2032?
3. What are the key factors driving the global peripheral vascular devices market?
4. What has been the impact of COVID-19 on the global peripheral vascular devices market?
5. What is the breakup of the global peripheral vascular devices market based on the device type?
6. What is the breakup of the global peripheral vascular devices market based on the end user?
7. What are the key regions in the global peripheral vascular devices market?
8. Who are the key players/companies in the global peripheral vascular devices market?
Peripheral vascular disease (PVD) is a circulatory condition caused due to the narrowing, blockage, or spasms in the blood vessels located outside the heart and brain. Such occurrences reduce the blood flow through the vessels, resulting in weakness, pain, gangrene, hair loss on the legs, numbness, and muscle heaviness. Peripheral vascular devices, such as angioplasty catheters, peripheral guidewires, vena cava filters, stent grafts, and embolic protection devices (EPD), are used to treat artery blockages and narrowing. These blockages, particularly found in the peripheral vasculature, are caused by plaque build-up, which limits the blood vessels and reduces blood flow to the body parts. Peripheral vascular devices are safe, minimize the risk of infection and irritation, improve blood flow, and supply oxygenated blood through arteries.
Peripheral Vascular Devices Market Trends
The increasing prevalence of venous diseases or CVI (chronic venous insufficiency) across the globe is creating a positive outlook for the market. Peripheral vascular devices provide sufficient blood flow to the brain, legs, and feet for proper functioning. Additionally, the rising geriatric population and the increasing incidences of various ailments, such as peripheral artery disease (PAD) and blockages, are favoring the market growth. Furthermore, this can be attributed to changing lifestyle habits, including smoking and high alcohol consumption, coupled with physical inactivity and unhealthy dietary habits.Apart from this, the growing inclination toward minimally invasive surgeries (MIS) due to fewer complications, less postoperative pain, shortened hospital stay, and faster recovery times are providing an impetus to the market growth. Moreover, the widespread adoption of atherectomy devices owing to the increasing prevalence of atherosclerosis, obesity, and lifestyle-related disorders is positively influencing the market growth. Other factors, including the significant growth in the healthcare industry, rising expenditure capacities of consumers, and extensive research and development (R&D) activities, are anticipated to drive the market toward growth.
Key Market Segmentation
This report provides an analysis of the key trends in each sub-segment of the global peripheral vascular devices market report, along with forecasts at the global, regional and country level from 2024-2032. The report has categorized the market based on device type and end user.Breakup by Device Type:
- Peripheral Vascular Stents
- Peripheral Transluminal Angioplasty (PTA) Balloon Catheters
- Peripheral Transluminal Angioplasty (PTA) Guidewires
- Atherectomy Devices
- Embolic Protection Devices
- Inferior Vena Cava Filters
- Others
Breakup by End User:
- Hospitals and Clinics
- Ambulatory Care Centers
- Specialty Clinics
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, B. Braun SE (B. Braun Holding GmbH & Co. KG), Becton, Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corporation, Cook Group Incorporated, Cordis Corporation, iVascular S.L.U., Koninklijke Philips N.V., Medtronic plc and Terumo Medical Corporation.Key Questions Answered in This Report
1. What was the size of the global peripheral vascular devices market in 2023?2. What is the expected growth rate of the global peripheral vascular devices market during 2024-2032?
3. What are the key factors driving the global peripheral vascular devices market?
4. What has been the impact of COVID-19 on the global peripheral vascular devices market?
5. What is the breakup of the global peripheral vascular devices market based on the device type?
6. What is the breakup of the global peripheral vascular devices market based on the end user?
7. What are the key regions in the global peripheral vascular devices market?
8. Who are the key players/companies in the global peripheral vascular devices market?
Table of Contents
1 Preface3 Executive Summary10 Value Chain Analysis12 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Peripheral Vascular Devices Market
6 Market Breakup by Device Type
7 Market Breakup by End User
8 Market Breakup by Region
9 SWOT Analysis
11 Porters Five Forces Analysis
13 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Abbott Laboratories
- B. Braun SE (B. Braun Holding GmbH & Co. KG)
- Becton, Dickinson and Company
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- Cook Group Incorporated
- Cordis Corporation
- iVascular S.L.U.
- Koninklijke Philips N.V.
- Medtronic plc
- Terumo Medical Corporation
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 138 |
| Published | April 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 11.6 Billion |
| Forecasted Market Value ( USD | $ 19.8 Billion |
| Compound Annual Growth Rate | 6.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
